HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Burkitt's lymphoma cell lines producing truncated mu immunoglobulin heavy chains lacking part of the variable region.

Abstract
Burkitt's lymphoma cell lines Ly91, Ly47 and JBL2 contained intracytoplasmic mu chains without light chains and variably expressed membrane mu chains. All three cell lines produced similarly truncated heavy chains with an apparent molecular mass of 64 kDa instead of the normal 74 kDa. Both the intracellular and secreted forms of the mu chains were similarly truncated. The membrane and the secreted forms of mu mRNAs were shorter than normal. The cDNAs contained a leader sequence, followed by about one third of a variable region (VH), then by the constant region (C mu). Interruption of the variable region took place near the end of the framework region 1 (FR 1) in Ly 47 and JBL2, and within the complementarity determining region 1 (CDR1) in Ly91. In the three lines, the joining between VH and C mu maintained the normal open reading frame throughout the variable and constant regions.
AuthorsM Cogné, S Mounir, J L Preud'homme, F Nau, P Guglielmi
JournalEuropean journal of immunology (Eur J Immunol) Vol. 18 Issue 10 Pg. 1485-9 (Oct 1988) ISSN: 0014-2980 [Print] Germany
PMID2847931 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Immunoglobulin Variable Region
  • Immunoglobulin mu-Chains
  • DNA
  • Endonucleases
  • Single-Strand Specific DNA and RNA Endonucleases
Topics
  • Amino Acid Sequence
  • Base Sequence
  • Blotting, Northern
  • Blotting, Southern
  • Burkitt Lymphoma (genetics)
  • Cell Line
  • Cloning, Molecular
  • DNA (genetics)
  • Endonucleases (metabolism)
  • Gene Rearrangement
  • Genes, Immunoglobulin
  • Humans
  • Immunoglobulin Variable Region (genetics)
  • Immunoglobulin mu-Chains (genetics)
  • Molecular Sequence Data
  • Precipitin Tests
  • Single-Strand Specific DNA and RNA Endonucleases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: